2026 - Introduced
Rhode Island S.B. 3022
  • Requires health insurers to provide equal access to FDA-approved non-opioid pain medications, eliminating prior authorization and step therapy requirements that currently give opioids a prescribing advantage
2026 - Introduced
South Dakota H.B. 1085
  • Prohibits South Dakota insurers from denying coverage of a prescribed non-opioid medication in favor of an opioid.
  • Bars insurers from imposing stricter utilization controls or higher cost-sharing for non-opioid drugs than for clinically appropriate opioid or narcotic drugs.
2024 - Passed
Tennessee H.B.37
  • Aligns group health insurance plans providing coverage for state employees with Medicaid non-opioid parity policy, ensuring reimbursement of all FDA-approved non-opioid drugs.
2026 - Passed
Utah Senate Concurrent Resolution 5
  • Directs the state employee health plan to include at least one clinically appropriate non-opioid prescription alternative for each covered opioid.
  • Prohibits health plan from establishing more restrictive or extensive utilization controls for non-opioid treatments than the least restrictive or extensive utilization control for any opioid.
2026 - Introduced
Virginia H.B. 516
  • Prohibits commercial health insurers from imposing limitations or utilization controls on coverage of a covered FDA-approved non-opioid drug that are more restrictive or less favorable to the enrollee relative to the coverage of an opioid drug for the treatment or management of pain.
2026 - Introduced
Washington S.B. 5916
  • Prohibits public and private health plans from disadvantaging non-opioid pain medications that are more restrictive or less favorable to the enrollee relative to the coverage of an opioid drug for the treatment or management of pain.
  • Requires the state to publish an educational pamphlet on non-opioid pain treatment alternatives.